Bayer AG (WBO:BAYN) Margin of Safety % (DCF Dividends Based): N/A (As of Jun. 30, 2026)


WBO:BAYN Bayer AG WBO:BAYN
57 GF Score
Price €48.10
GF Value €27.36
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bayer AG Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Bayer AG's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

WBO:BAYN vs LLY, JNJ, ABBV: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bayer AG Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Bayer AG's Margin of Safety % (DCF Dividends Based) falls into.


WBO:BAYN
57GF Score
Bayer AG WBO:BAYN
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (WBO:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of €48.10 is trading 75.8% above its estimated GF Value™ of €27.36. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WBO:BAYN:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €27.36 vs. price of €48.10 (75.8% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the WBO:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
57GF Score

Get the complete analysis for WBO:BAYN

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€48.10
Price
€27.36
GF Value